Very recently, an independent study indicated that ZC3H13 suppressed the progression of HCC through m6A-PKM2-mediated glycolysis and sensitized HCC cells to cisplatin, which offered a novel insight into ZC3H13 downregulation in HCC (Wang et al., 2021b). This evidence concerns the gene ZC3H13 and hepatocellular carcinoma.